Apolipoprotein L1 (APOL1) is a human-specific serum protein bound to high-density lipoprotein (HDL) particles. This protein allows human resistance to infection by African trypanosomes except for two subspecies, Trypanosoma brucei rhodesiense and T. b. gambiense, the causative agents of sleeping sickness or African trypanosomiasis. This disease infects 20 000 people in sub-Saharan Africa and without treatment, infection is almost always fatal. T. b. rhodesiense resists APOL1 through direct protein neutralization by the Serum Resistance-Associated (SRA) protein. T. b. gambiense does not express SRA, and its mechanism of resistance to APOL1 is orchestrated upon a recently characterized multifactorial defense mechanism.<p><p>The mechanism by which the human serum sensitive parasites are killed following APOL1 uptake is described as the result of the lysosomal swelling induced by the generation of ionic pores within the lysosomal membrane.<p>We show here that preventing the osmotic lysosomal swelling in a hyperosmotic culture condition does not prevent the cell death. In addition, APOL1 appears to trigger some programmed cell death events in the cell such as a fast mitochondrial depolarization followed by a DNA laddering and fragmentation. Furthermore, we show an implication of the endonuclease G (TbEndoG), known to be a key actor in the regulation of cell death process and a kinesin (TbKIFC1), which might be the transporter of APOL1 for the endosomes to the mitochondrion.<p> <p>In addition, by producing different recombinant human APOL proteins in E. coli and test their activity on T. brucei, we were able to show that APOL3, an other member of the APOL family, also possesses a trypanolytic activity like APOL1 beneath the fact it is not a secreted protein. APOL3 does not only kill T. b. brucei but is also able to lyse APOL1-resistant subspecies such as rhodesiense and gambiense, in vitro and confirmed in vivo when the recombinant APOL3 were injected in infected mice. A beginning of an action mechanism is described herein showing a pH-independent activity for this protein oppositely to APOL1, conferring its specificity.<p>It is thus conceivable to use this recombinant protein as a first step of a potent curative agent against gambiense or rhodesiense since the few currently available drugs for treatment of African trypanosomiasis, that are outdated, show problems with toxicity and resistance. <p><p>/ <p><p>L’ Apolipoprotéine L1 (APOL1) est une protéine sérique humaine associée aux lipoprotéines de haute densité (HDL). Cette protéine confère la résistance à l'infection des trypanosomes africains à l'exception des deux sous-espèces, Trypanosoma brucei rhodesiense et T. b. gambiense, les agents responsables de la maladie du sommeil ou trypanosomiase africaine. Cette maladie infecte 20 000 personnes en Afrique sub-saharienne et en l'absence de traitement, l'infection est presque toujours mortelle. T. b. rhodesiense résiste à l’APOL1 grâce à une neutralisation directe d’APOL1 par une protéine appelé SRA (Serum Resistant-Associated). T. b. gambiense n'exprime pas SRA, et sa résistance à l’APOL1 est orchestrée par un mécanisme de défense multifactorielle récemment caractérisé 1.<p>Le mécanisme par lequel les parasites sensibles au sérum humain sont tués suivant l’entrée de l’APOL1 est décrit comme le résultat d’un gonflement du lysosome induit par la génération de pores ioniques à l'intérieur de la membrane lysosomiale2. Nous montrons ici que le gonflement osmotique du lysosome peut être empêché en condition de culture hyper osmotique, sans néanmoins empêcher la mort de la cellule. En outre, l’APOL1 semble déclencher des événements de mort cellulaire programmée dans la cellule, tels qu’une dépolarisation mitochondriale rapide suivie d'une fragmentation de l’ADN. De plus, nous montrons une implication de l'endonucléase G (TbEndoG), connu pour être un acteur clé dans la régulation du processus de mort cellulaire et d’une kinésine (TbKIFC1) qui pourrait avoir le rôle de transporter l’APOL1 des endosomes vers la mitochondrie.<p>Nous avons également pu montrer que l’APOL3, un autre membre de la famille des APOLs humaines, possède tout comme l’APOL1, une activité trypanolytique bien que cette protéine ne soit pas sécrétée en condition physiologique. De manière intéressante, l’APOL3 ne tue pas seulement T. b. brucei, mais est également capable de tuer les sous-espèces résistantes à l’APOL1 tels que rhodesiense et gambiense, in vitro et in vivo lorsque de l’APOL3 recombinante est injectée dans des souris infectées. La spécificité d’action de l’APOL3 pourrait être liée à une indépendance au pH, au contraire de l’APOL1. Il pourrait être envisagé d'utiliser cette protéine recombinante comme agent curatif contre gambiense ou rhodesiense du fait que les médicaments actuellement disponibles pour le traitement de la trypanosomiase africaine montrent des problèmes de toxicité et de résistance.<p><p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished

Acute and chronic sleeping sickness are fatal neglected tropical diseases caused by Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense respectively (members of the sub-genus Trypanozoon). Accurate diagnostics are needed to guide treatment since the symptoms of disease are non-specific and the drugs that are used for treatment are too toxic to be administered to unconfirmed cases. Tests need to be simple enough to confirm clinical diagnosis of sleeping sickness in poorly-resourced, peripheral health centres and for use as epidemiological tools to detect T. b. rhodesiense in the zoonotic reservoirs of infection. This study focuses upon LAMP (loop-mediated isothermal amplification) as a novel diagnostic for sleeping sickness that may serve to bridge the gap between the need for sensitive, specific molecular diagnostics on the one hand and ‘field-friendly’ diagnostics on the other. Here, two previously published LAMP assays for Trypanozoons were compared to classic PCR based methods for the diagnosis of Trypanozoon infection status in 428 cattle blood samples. The results did not support the use of LAMP as an improved system for surveillance of T. b. rhodesiense in the zoonotic cattle reservoir. T. b. rhodesiense and T. b. gambiense subspecies specific LAMP assays were evaluated against traditional reference subspecies specific PCR tests, using DNA purified from 86 cryopreserved trypanosome isolates. Novel LAMP assays for these subspecies were also designed and evaluated. Both the published and novel assays for T. b. rhodesiense (targeting different regions of the SRA gene) were sensitive, specific and reliable when applied to purified DNAs, but were less consistent on field samples. The novel T. b. gambiense LAMP (targeting TgsGP) was sensitive and specific but this was not the case for the published LAMP assay (targeting the 5.8S rRNA gene). However reliability may be less than optimal for LAMP TgsGP. Finally, simple endpoint readout methods for LAMP were evaluated. The colour change reagent hydroxynaphthol blue was identified as the best currently available method taking cost, ease of use and reliability into consideration. In 2009 the number of reported sleeping sickness cases fell below 10,000 for the first time in 50 years. Improved LAMP diagnostics could facilitate the diagnosis of sleeping sickness and support the continued fight against this neglected, but deadly disease.

The bloodstream form of Trypanosoma brucei differentiates into the stumpy form in the mammalian bloodstream, completing differentiation into the procyclic form on uptake by the tsetse fly. The underlying genetic events occurring during this differentiation process in pleomorphic cell lines were investigated through whole-genome microarray studies of key time points during differentiation from stumpy form cells to the procyclic form found in the insect midgut. The microarray was extensively validated and bioinformatic experiments conducted to detect motifs over represented in stumpy form or slender form cells. A positional-dependent motif was identified that was over represented in stumpy form cells, possibly representing a regulatory domain. The transcripts found to be enriched in stumpy form cells included a chloride channel, although RNAi directed against this gene showed no phenotype, suggesting the protein is redundant, as three other homologous proteins exist in the genome and showed similar mRNA profiles on the microarray. Stumpy form cells are G0 arrested and two proteins implicated in G0/G1 regulation in other organisms, Target of Rapamycin (Tor) and Cdh1, were investigated in T. brucei to determine whether these proteins were involved in differentiation. The result of depletion of either protein was rapid cell death in bloodstream form cells, although treatment with the drug rapamycin did not have any effect on the cells in contrast to other eukaryotes where this drug causes G1 arrest. A method for synchronisation of bloodstream form cells was also designed using a supravital dye and flow cytometry to allow investigation into cell cycle-dependent processes. This method was particularly suitable for harvesting populations enriched in G0/G1 stage cells, however differentiation of the isolated G0/G1 and G2/M populations did not show significantly different differentiation kinetics.

During the bloodstream stage of the Trypanosoma brucei lifecycle, the parasite exists in two different states: the proliferative slender form and the non-proliferative, transmissible, stumpy form. The transition from the slender to stumpy form is stimulated by a density-dependent mechanism and is important in infection dynamics, ordered antigenic variation and disease transmissibility. The slender to stumpy transition and the contribution of stumpy formation to within-host dynamics have been difficult to analyse, however, because cell-type specific markers have been restricted to imprecise morphological criteria. PAD1 is a recently identified stumpy-specific protein which acts as a molecular marker for stumpy formation and a functional marker for transmission. Here, the control of stumpy-specific gene expression via the 3’UTR has been analysed, identifying that there are repressive elements in the 3’UTR preventing inappropriate expression during the slender life stage. Further, both pleomorphic and monomorphic transgenic reporter cell lines utilising the PAD1 3’UTR have been created that report on stumpy formation in vitro and these have been used for the analysis of stumpyinducing chemical compounds. Finally, a sensitive and accurate qRT-PCR assay has been developed and optimised that faithfully reports both parasitaemia and stumpy formation throughout host infection. Using a chronic infection rodent model, stumpy levels have been monitored on the basis of conventional morphological and cell cycle assays, as well as by qRT-PCR for PAD1 expression. The results define the temporal order of events that result in the generation of stumpy forms early in a parasite infection and thereafter describe the dynamics of slender and stumpy forms in chronic infections extending over several weeks. This quantitative data has allowed the mathematical modelling of transmission competence in trypanosome infections, suggesting dominance of transmission stages throughout infection.

Trypanosoma congolense is a protozoan parasite transmitted by tsetse flies. It causes bovine trypanosomosis, the major disease for livestock in sub-Saharan Africa. Control methods include trypanocidal drugs and vector control, but none is fully satisfactory, due to resistance and environmental issues. A method that would have the greatest impact on controlling the disease is vaccination. However, development of a conventional vaccine has been hampered by the mechanism of antigenic variation, which allows the parasite to evade the host’s immune system. An alternative strategy in vaccine design is to target the bioactive compounds released by dead and dying trypanosomes. This approach is termed ‘‘anti-disease’’, and does not affect the survival of the parasite but targets the pathogenic factors released by the trypanosomes. The development of a successful anti-disease vaccine necessitates knowledge of all pathogenic factors involved in the disease process. Several macromolecules, primarily peptidases, have been implicated in the pathogenesis of trypanosomosis. Pyroglutamyl peptidase type I (PGP) was shown to be involved in abnormal degradation of thyrotropin- and gonadotropin-releasing hormones in rodents infected with T. brucei, but to date no data are available on the T. congolense PGP. Molecular cloning and expression in E. coli of the coding sequence of T. congolense PGP, as well as the enzymatic characterisation of the recombinant protein, are reported here, completed by the development of reverse genetics tools for studies of gene function. A 678 bp PCR fragment covering the complete open reading frame of PGP was cloned and sequenced. The deduced amino acid sequence showed 52% and 29% identity with the T. brucei and Leishmania major enzymes respectively. The catalytic residues Glu, Cys and His described in Bacilus amyloliquefaciens PGP are conserved in the T. congolense sequence. PGP was expressed in bacterial systems as a soluble active, 26 kDa enzyme. The recombinant enzyme showed activity specific for the fluorescent substrate pGlu-AMC, with a kcat/Km of 1.11 s-1μM. PGP showed activity in the pH 6.5-10 range, with maximal activity at pH 9.0. The enzyme was strongly inhibited by sulfhydryl-blocking reagents such as iodoacetic acid and iodoacetamide with a kass of 125 M-1 s-1 and 177 M-1 s-1 respectively. Antibodies raised in chickens against the recombinant enzyme allowed the detection of native PGP in both procyclic and bloodstream T. congolense developmental stages, and displayed complete inhibition of the enzyme in vitro at physiological concentrations. To get insight into the role of PGP in parasite biology and trypanosomosis progression, two types of vectors for reverse genetics studies were developed. For RNA interference, a 400 bp 3′ end segment of the PGP open reading frame was cloned into the plasmid p2T7Ti, that will allow PGP gene down-regulation upon integration into the genome of an engineered tetracycline-inducible strain such as TRUM:29-13. For gene knock-out, several rounds of molecular engineering were carried-out in order to create two plasmid vectors, pGL1184-based (blasticidin resistance) and pGL1217-based (neomycin resistance), each bearing 200 bp-long regions at the 5′ and 3′ ends of the PGP open reading frame. In subsequent studies, taking advantage of the recent advances in culture and transformation of T. congolense, these plasmids will allow the creation of single and double knock-out mutants of PGP. / Thesis (M.Sc.)-University of KwaZulu-Natal, Pietermaritzburg, 2012.

Trypanosoma congolense is a major causative agent of the bovine disease trypanosomosis which has a considerable economic impact on sub-Saharan Africa. Current control methods for trypanosomosis are unsatisfactory and vaccine development has been hampered by antigenic variation. An anti-disease vaccine is based on the idea that disease is caused by the pathogenic factors released by the parasite, rather than by the parasite itself. Therefore, if these pathogenic factors could be neutralised by antibodies produced by vaccination, the disease could be circumvented. The method used here for identification of novel pathogenic factors is based on the concept that trypanotolerant cattle are able to mitigate the disease by generating a specific immune response against a few key antigens (pathogenic factors). Two immuno-affinity columns were therefore prepared: one containing IgG from noninfected sera and a second column containing IgG from trypanotolerant N’Dama cattle serially infected with T. congolense. The differential binding of antigens to the two columns allowed identification of antigens specifically recognised by the immune system of a trypanotolerant animal, i.e. potential pathogenic factors. The most promising antigens identified included several variant cathepsin L-like cysteine peptidases (CPs) and the Family M1 Clan MA aminopeptidases (APs). For the CPs, a study of the genetic organisation was conducted in order to further understand the variability present in this gene family. To this end, two different mini-libraries of cathepsin L-like genes were prepared: one in which genes as different as possible from congopain (the major CP of T. congolense) were selected, and a second which contained all possible genes present in the congopain array. Analysis of the sequences obtained in these two mini-libraries showed that there was significant variability of the genes within the congopain array. Two variants of CPs, chosen for differences in their catalytic triads, were cloned for expression. The recombinantly expressed CP variants differed in substrate preferences from one another and from C2 (the recombinant truncated form of congopain), and surprisingly, all enzymes were active at physiological pH. The two APs were cloned and expressed as insoluble inclusion bodies in an E. coli system, and subsequently refolded. The refolded APs showed a substrate preference for H-Ala-AMC, an optimum pH of 8.0, localisation to the cytoplasm and inhibition by puromycin. The two APs were not developmentally regulated and present in procyclic, metacyclic and bloodstream form parasites. Down-regulation of both APs by RNAi resulted in a slightly reduced growth rate in procyclic parasites in vitro. Immunisation of BALB/c mice with the APs did not provide protection when challenged with T. congolense. For an anti-disease vaccine to be protective, it would possibly have to include all pathogenic factors, including the two APs and at least one CP described in the present study. / Thesis (Ph.D.)-University of KwaZulu-Natal, Pietermaritzburg, 2010.

The Luangwa Valley is recognised as a focus of endemic infection with human sleeping sickness caused by Trypanosoma bruceirhodesiense. Extensive infection of the wildlife population with many species of trypanosome has been identified and livestock keeping is almost non-existent due to losses from trypanosomiasis and predation by wild animals. The aim of this study was to investigate the ecology of trypanosomiasis in this mult-host wildlife community, relatively free from anthropogenic influences. Particular focus was to be applied to the role of common warthog, phacocoerus aethipicus, within the reservoir community. The thesis initially reviews the history of protected area management in the Luangwa Valley. Remotely sensed imagery is then used in a study of the vegetation units of Luambe National Park. A supervised classification algorithm utilising fuzzy logic is used to generate a land cover classification of the part with an overall accuracy of 71%. Surveys of the tsetse and wild mammal population in Luambe national park are then presented. Data collected from the tsetse survey are analysed using generalised linear models with mixed effects to investigate factors influencing the trypanosome prevalence in tsetse, as well as the distribution and apparent density of tsetse. The density of tyhe host mammal population is assessed using distance sampling techniques and the distribution of warthog burrows mapped. Finally, a cross-sectional survey of trypanosome prevalence in the wild animal population of the Luangwa Valley is described, using novel molecular techniques for diagnosis. Risk factors for infection are analysed using logistic regression analysis and the host distribution for each trypanosome species described.

Memoria para optar al Título Profesional de Médico Veterinario / En el presente trabajo, se analizó la evolución de la infección con Trypanosoma cruzi, en ratones Balb/c experimentalmente infectados con 2.000 trypomastigotes sanguíneos de la cepa Tulahuén o del clon Dm28c del parásito, evaluando no sólo prepatencia y niveles de parasitemia, sino también su correlación con el número de pseudoquistes, la magnitud del daño inflamatorio, en el tejido cardiaco y músculo esquelético y la mortalidad acumulada de los ratones infectados. Los resultados mostraron una prepatencia, similar, de 5 días en ambos grupos de ratones. En relación al nivel máximo de parasitemia, este alcanzó un máximo de 16,23 ± 2,21 x 105 parásitos/mL a los 11 día post infección, en los ratones infectados con la cepa Tulahuén, y que no fue significativamente distinto del nivel máximo de, 19,37 ± 1,78 x 105parásitos/mL, alcanzado por los ratones infectados con el clon Dm28c, a los 19 días post infección (p > 0,05). Todos los ratones sucumbieron a la infección con T. cruzi, alcanzando un 100% de mortalidad acumulada a los 19 días post infección con la cepa Tulahuén y a los 21 días en aquellos infectados con el clon Dm28c. El estudio histopatológico mostró un número similar de pseudoquistes, tanto en el tejido cardiaco, como en músculo esquelético de ambos grupos de ratones infectados con T. cruzi. No se observaron diferencias en la evolución del daño inflamatorio en músculo esquelético de todos los ratones infectados; sólo se observaron diferencias en la evolución del daño inflamatorio en el tejido cardiaco. En los ratones infectados con la cepa Tulahuén, el daño inflamatorio en el tejido cardiaco se inicia tempranamente en la primera semana post infección y alcanza su mayor severidad y magnitud a partir de la segunda semana post infección experimental. En los ratones infectados con el clon Dm28, en cambio, el aumento en el número de pseudoquistes y en la magnitud y severidad del daño cardiaco es de más lenta evolución alcanzando su mayor expresión a los 21 días post infección experimental. / Proyecto LIHBAC-001/13

Memoria para optar al Titulo Profesional de Médico Veterinario / Se infectaron ratones de la cepa ACA, machos y hembras, con 200 y 2000 trypomastigotes sanguíneos del clon Dm28c de Trypanosoma cruzi. Todos los animales se comportaron como susceptibles a la infección, independientemente del sexo y la dosis de inóculo inicial. Los animales, tanto machos como hembras, infectados con 2000 parásitos presentaron niveles de parasitemia significativamente más altos que los ratones infectados con la dosis menor. A su vez, los machos desarrollaron niveles de parasitemia más altos que las hembras, tanto al infectar con 200 como con 2000 parásitos. A pesar de comportarse todos los animales experimentales como susceptibles, el período de supervivencia fue significativamente más prolongado en los machos infectados con 200 comparado con lo ocurrido con los machos infectados con 2000 parásitos. Las hembras infectadas con 2000 sobrevivieron más tiempo que los machos infectados con la misma dosis de parásitos. No se observaron diferencias significativas en el tiempo de supervivencia, al comparar hembras infectadas con 200 y 2000 ni tampoco en el caso de machos y hembras infectadas con 200 parásitos. Al parecer, la principal característica afectada por las variables sexo y dosis de inóculo inicial es el nivel de parasitemia

Memoria para optar al Título Profesional de Médico Veterinario / El objetivo de esta memoria fue estudiar la conducta de alimentación y defecación de Mepraia spinolai provenientes de laboratorio y terreno en diferentes hospederos silvestres en condiciones de laboratorio. Se analizaron las variaciones en el tiempo de picada, tiempo de ingesta de sangre, tiempo de defecación y cantidad de sangre ingerida de la vinchuca. Con el fin de comprobar el efecto de hospederos diferentes sobre estas conductas, en función de la calidad de sangre, conducta del hospedero y tiempo de coevolución con el insecto, se realizaron experimentos, enfrentando conejos y ratones silvestres por separado a vinchucas sometidas a ayuno. Para los experimentos se utilizaron tubos de rejilla con el diámetro suficiente para que ingresara un conejo, Oryctolagus cuniculus, y otro para un ratón, Octodon degus. Estos tubos se colocaron dentro de una cámara de vidrio con un ejemplar del hospedero seleccionado en ese momento y con una vinchuca previamente sometida a un ayuno de 45 días. Según tiempo de picada, hubo diferencias significativas en la interacción entre el origen de las vinchucas y tipos de hospederos (p = 0,015). En cuanto al tiempo de ingesta de sangre fue significativo según el tipo de hospedero (p = 0,039). M. spinolai demoró más tiempo en alimentarse con conejo. No hubo diferencias significativas en el tiempo de defecación. Por otra parte, la cantidad de sangre ingerida tubo significancia según en origen de las vinchucas, en donde M.spinolai de terreno consumió mayor proporción de sangre que las de laboratorio (p = 0,03). El mayor tiempo ocupado en alimentarse en el conejo, sugiere que es favorable para el insecto la menor reactividad del hospedero. Sin embargo, el conjunto de datos indican que M. spinolai es un insecto oportunista que se alimenta sin hacer diferencias entre el tipo de hospedero. El presente estudio aportó datos para definir mejor la importancia epidemiológica de dos hospederos habituales de Mepraia spinolai. Queda por determinar la prevalencia de T. cruzi en roedores nativos y conejos europeos para estimar la existencia de efectos del hospedero sobre la persistencia del parásito / FONDECYT No.1040711